Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionCaption Management, LLC
Latest Disclosed Ownership280,058 shares
Latest Disclosed Value $ 8,435,347
Caption Management, LLC ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 280,058 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $8,435,347 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 65,000 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 330.86% during the quarter. The current value of the position is $9,194,304 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 1,089,500 of underlying shares valued at $32,815,740 USD and put options representing 674,500 of underlying shares valued at $20,315,940 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 280,058 215,058 330.86 8,435 315.93 0.0493
2026-02-17 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 65,000 65,000 2,029 0.0139
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -259,800 -100.00 0 -100.00
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 259,800 213,664 463.12 3,993 293.01 0.0384
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 46,136 -138,164 -74.97 1,017 -69.41 0.0096
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 184,300 141,700 332.63 3,321 379.91 0.0530
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 42,600 42,600 692 0.0107
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -369,461 -100.00 0 -100.00
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 369,461 13,471 3.78 3,769 40.60 0.0580
2023-08-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 355,990 355,990 2,681 0.0475
2023-05-15 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -410,000 -100.00 0 -100.00
2023-02-14 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 410,000 -472,115 -53.52 3,739 -47.48 0.0583
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 882,115 51,627 6.22 7,119 14.00 0.0982
2022-08-15 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 830,488 243,500 41.48 6,245 13.30 0.0861
2022-05-13 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 586,988 -213,012 -26.63 5,512 -13.98 0.0663
2022-02-11 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 800,000 800,000 6,408 0.0718
2021-08-16 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -6,000 -100.00 0 -100.00
2021-05-17 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 6,000 6,000 69 0.0015
2019-05-14 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 0 -261,602 -100.00 0 -100.00
2019-01-30 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 261,602 261,602 4,034 0.3219
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,089,500 542.77 32,816 520.32 n/a n/a n/a
2026-02-17 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 169,500 111.88 5,290 227.35 n/a n/a n/a
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 80,000 1,616 n/a n/a n/a
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 363,300 -28.06 5,584 -49.84 n/a n/a n/a
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 505,000 -8.18 11,130 12.30 n/a n/a n/a
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 550,000 -12.00 9,911 -2.41 n/a n/a n/a
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 625,000 646.71 10,156 759.95 n/a n/a n/a
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 83,700 1,181 n/a n/a n/a
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 27,800 284 n/a n/a n/a
2023-05-15 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 2,359,200 40.01 21,516 58.23 n/a n/a n/a
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,685,000 0.00 13,597 7.31 n/a n/a n/a
2022-08-15 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,685,000 0.00 12,671 -19.92 n/a n/a n/a
2022-05-13 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,685,000 0.00 15,822 17.23 n/a n/a n/a
2022-02-11 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 1,685,000 13,497 n/a n/a n/a
2021-05-17 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 50,000 482 n/a n/a n/a
2019-08-13 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 25,000 -90.98 391 -90.85 n/a n/a n/a
2019-01-30 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 277,200 -21.29 4,273 -43.67 n/a n/a n/a
2018-11-14 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 352,200 7,585 n/a n/a n/a
2018-05-15 2018-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 329,800 6,249 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 674,500 20,316 n/a n/a n/a
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 662,300 21.48 10,180 -15.29 n/a n/a n/a
2025-02-14 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 545,200 211.54 12,016 281.10 n/a n/a n/a
2024-11-14 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 175,000 3,154 n/a n/a n/a
2024-02-14 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 402,700 2.18 4,108 38.42 n/a n/a n/a
2023-08-14 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 394,100 2,968 n/a n/a n/a
2023-05-15 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 1,976,000 0.00 18,021 13.01 n/a n/a n/a
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 1,976,000 0.00 15,947 7.31 n/a n/a n/a
2022-08-15 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 1,976,000 0.00 14,860 -19.91 n/a n/a n/a
2022-05-13 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 1,976,000 0.00 18,554 17.22 n/a n/a n/a
2022-02-11 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 1,976,000 15,828 n/a n/a n/a
2021-11-12 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 50,000 0.00 495 -14.06 n/a n/a n/a
2021-05-17 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 50,000 576 n/a n/a n/a
2020-05-14 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 75,000 735 n/a n/a n/a
2019-08-13 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 25,000 -93.02 391 -92.92 n/a n/a n/a
2019-01-30 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 358,400 0.00 5,526 -28.40 n/a n/a n/a
2018-11-14 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 358,400 7,718 n/a n/a n/a
2018-05-15 2018-03-31 13F/A TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 394,800 7,481 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.